David A Bumcrot

USPTO Granted Patents = 53 (Patent Applications = 33)

CIPO Patents = 5 (Patent Applications = 5)

EPO Patents = 13 (Patent Applications = 33)

Average Co-Inventor Count = 3.1

ph-index = 12

Forward Citations = 823(Granted Patents)

Forward Citations (Not Self Cited) = 765(Oct 12, 2025)

Location History:

Blemont, MA (US) (2021)
Cambridge, MA (US) (2014 - 2022)
Belmont, CA (US) (2021 - 2022)
Belmont, MA (US) (2000 - 2024)

Company Filing History:

29 out of 443

Alnylam Pharmaceuticals, Inc.

patents

13 out of 50

Editas Medicine, Inc.

patents

4 out of 4

Camp4 Therapeutics Corporation

Imperial Cancer Research Technology, Ltd.

Arrowhead Pharmaceuticals, Inc.

patents

10. 3 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...

53 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12460231 - Crispr/CAS-related methods and compositions for treating primary open angle glaucoma (2025-11-04),

2. 12319916 - Modulation of gene transcription using antisense oligonucleotides targeting regulatory RNAs (2025-06-03),

3. 12234449 - CRISPR/Cas-related methods and compositions for treating Leber's congenital amaurosis 10 (LCA10) (2025-02-25),

4. 12145963 - Phenothiazine derivatives and uses thereof (2024-11-19),

5. 12031133 - GNAQ targeted dsRNA compositions and methods for inhibiting expression (2024-07-09),

6. 11834649 - CRISPR/CAS-related methods and compositions for treating herpes simplex virus (2023-12-05),

7. 11542290 - Phenothiazine derivatives and uses thereof (2023-01-03),

8. 11530408 - Therapeutic compositions (2022-12-20),

9. 11390861 - CRISPR/cas-related methods and compositions for treating herpes simplex virus (2022-07-19),

10. 11339437 - Compositions and methods for treating CEP290-associated disease (2022-05-24),

11. 11268086 - CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10) (2022-03-08),

12. 11266655 - Methods and compositions for treating urea cycle disorders (2022-03-08),

13. 11242525 - CRISPR/CAS-related methods and compositions for treating sickle cell disease (2022-02-08),

14. 11198876 - Compositions and methods for inhibiting expression of TMPRSS6 gene (2021-12-14),

15. 11141493 - Compositions and methods for treating CEP290-associated disease (2021-10-12),

Title: The Innovative Journey of David A Bumcrot

Introduction: David A Bumcrot, a talented inventor hailing from Belmont, MA (US), has made significant contributions to the field of innovations with his groundbreaking ideas and inventions.

Latest Patents: David A Bumcrot holds several patents in various industries, showcasing his diverse range of expertise and creativity in inventing new solutions to existing problems.

Career Highlights: Throughout his illustrious career, David A Bumcrot has been recognized for his innovative spirit and dedication to pushing the boundaries of what is possible. His inventions have not only improved efficiency in different sectors but have also positively impacted the lives of many.

Collaborations: David A Bumcrot has collaborated with leading companies, research institutions, and universities to further develop his inventions and bring them to the market. His collaborative efforts have led to the successful implementation of cutting-edge technologies in practical applications.

Conclusion: In conclusion, David A Bumcrot's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors. His contributions continue to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

This text is generated by artificial intelligence and may not be accurate.